RIZZI, Federica Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 1845
EU - Europa 1729
AS - Asia 960
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
SA - Sud America 1
Totale 4541
Nazione #
US - Stati Uniti d'America 1798
CN - Cina 802
IT - Italia 473
FI - Finlandia 311
SE - Svezia 285
UA - Ucraina 219
DE - Germania 162
RO - Romania 114
TR - Turchia 79
CA - Canada 47
FR - Francia 47
AT - Austria 42
IR - Iran 35
GB - Regno Unito 21
IN - India 17
VN - Vietnam 16
BE - Belgio 15
CZ - Repubblica Ceca 12
IE - Irlanda 8
KR - Corea 7
NL - Olanda 6
EU - Europa 5
CH - Svizzera 4
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 4
GR - Grecia 2
RU - Federazione Russa 2
CL - Cile 1
HU - Ungheria 1
LU - Lussemburgo 1
SC - Seychelles 1
Totale 4541
Città #
Chandler 348
Jacksonville 271
Ann Arbor 230
Dearborn 211
Beijing 170
Parma 157
Nanjing 145
Focsani 112
Princeton 93
San Mateo 91
Izmir 72
Jinan 60
Shenyang 49
Wilmington 47
Hebei 39
Toronto 39
Nanchang 38
Vienna 35
Des Moines 34
Changsha 29
Helsinki 29
Hefei 28
Kunming 27
Leawood 27
Fremont 25
Haikou 22
Zhengzhou 22
Guangzhou 21
Falls Church 18
Jiaxing 18
Redmond 18
Tianjin 17
Dong Ket 16
Houston 16
Augusta 15
Brussels 14
Piacenza 13
Taizhou 13
Trieste 13
Ardabil 12
Ardea 12
Seattle 12
Taiyuan 12
Bremen 11
Rome 11
Boardman 10
Norwalk 10
Chengdu 9
Monmouth Junction 9
Ningbo 9
Woodbridge 9
Zanjan 9
Fuzhou 8
Hangzhou 8
Modena 8
Ashburn 7
Grafing 7
Kocaeli 7
Milan 7
Lanzhou 6
Mumbai 6
Andover 5
Brno 5
Fairfield 5
New Delhi 5
Ottawa 5
Padova 5
Sacramento 5
Bologna 4
Bratislava 4
Correggio 4
Dublin 4
Las Vegas 4
Quzhou 4
Savignano Sul Rubicone 4
Tokyo 4
Torino 4
Wenzhou 4
Brooklyn 3
Düsseldorf 3
Mestre 3
Mongrando 3
Redwood City 3
Rockville 3
Albino 2
Arzano 2
Athens 2
Brisighella 2
Casina 2
Catanzaro 2
Cosenza 2
Ferrara 2
Geneva 2
Glasgow 2
Langfang 2
Pittsburgh 2
Qingdao 2
Rimini 2
Sabz 2
San Giuliano Milanese 2
Totale 2966
Nome #
Ionizing Radiation Effects on Hs 578Bst Microtubules 170
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 161
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 106
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 103
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 102
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 101
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 82
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 73
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 71
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 68
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 66
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 65
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 64
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 64
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 62
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 60
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 60
Clusterin: an “enigmatic” protein that turns to a novel tumour-suppressor gene 59
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 59
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 58
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 58
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 57
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 57
Clusterin is epigenetically repressed in human prostate cancer cells 57
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 56
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 56
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 56
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 56
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 54
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 54
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 51
Clusterin (CLU): From one gene and two transcripts to many proteins 49
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 49
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 49
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 48
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 48
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 47
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 47
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 47
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 47
Role of Clusterin in normal or tumoral bronchial human cells exposed to cigarette smoke 46
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 46
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 45
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 45
Effect of cold plasma treatment on physico-chemical parameters and antioxidant activity of minimally processed kiwifruit 45
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 45
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 44
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 44
EFFECT OF COLD PLASMA TREATMENT ON THE FUNCTIONAL PROPERTIES OF FRESH-CUT APPLES 44
Clusterin (CLU) and lung cancer 43
Effects of Clusterin knock down on prostate cancer progression in the tramp model 43
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 43
Chemoprevention of human prostate cancer by oral administration of green tea catechins 43
Molecular classification of Green Tea Catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 42
Development of a green fluorescent reporter plasmid for the bio-assay of anti-oxidant compounds 42
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 42
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 42
Molecular diagnosis of human prostate cancer (CaP) by RT-qPCR determination of gene expression signature 42
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 42
Sviluppo di un metodo in Real Time PCR per la diagnosi e la prognosi molecolare del carcinoma prostatico umano 42
Il tè verde nella chemoprevenzione oncologica 41
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 41
Espressione in forma ricombinante di differenti forme di clusterina 40
Molecular classification of green tea catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative RT real-time PCR gene profiling 39
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 39
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 39
Inhibition of human prostate cancer progression by administration of green tea catechins: a two years later follow-up update 39
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 38
Anticancer activity of green tea polyphenols in prostate gland 38
Clusterin (CLU) and prostate cancer 38
Targeting clusterin in prostate cancer 37
Redox Status and Proteostasis in Ageing and Disease 37
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 36
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model 36
Platelets contribute to amyloid-b aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release 36
Effect of plasma exposure time on the polyphenolic profile and antioxidant activity of fresh-cut apples 36
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 35
Nuclear CLU (nCLU) and the fate of the cell 34
Experimental development of a novel molecular tool for human prostate cancer (CaP) diagnosis by RT-qPCR determination of gene expression signature 34
Gene signature of TRAMP mice tumors for classification of Green Tea Catechins –sensitive and –resistant prostate cancer 34
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 34
Green tea polyphenols and prostate cancer chemoprevention 33
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 33
Clusterin is a very short half-life, poly-ubiquitinated protein controlling cell growth and proliferation in prostate cancer metastatic cells 32
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 32
Prognostic role of clusterin in resected adenocarcinomas of the lung 30
Clusterin is epigenetically repressed in human prostate cancer. 30
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment 25
HUMAN PROSTATE CANCER PREVENTION BY GREEN TEA CATECHINS: THE CLINICAL TRIAL AND PUTATIVE MOLECULAR MECHANISMS OF ACTION 23
Flexible PBAT-Based Composite Filaments for Tunable FDM 3D Printing 22
Study on the quality and stability of minimally processed apples impregnated with green tea polyphenols during storage 21
Clusterin Expression and Localization Are Affected by Rituximab and Doxorubicin Treatment in Non-Hodgkin Lymphoma Cells and B Lymphocytes 21
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 14
Oxidative Stress, Chronic Inflammation, and Amyloidoses 13
Totale 4677
Categoria #
all - tutte 7495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201875 0000 04 320 146523
2018/2019215 5546 1433 51 15101089
2019/20201439 1831936067 104187 16831 902582375
2020/2021986 5625330 22853 7849 1594718438
2021/2022571 2246816 2916 7175 264467151
2022/2023855 186208155173 1330 00 0000
Totale 4677